找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine Therapy of Breast Cancer III; Franco Cavalli Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 breast cancer.ca

[復(fù)制鏈接]
查看: 26676|回復(fù): 38
樓主
發(fā)表于 2025-3-21 17:07:36 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Endocrine Therapy of Breast Cancer III
編輯Franco Cavalli
視頻videohttp://file.papertrans.cn/310/309737/309737.mp4
叢書名稱ESO Monographs
圖書封面Titlebook: Endocrine Therapy of Breast Cancer III;  Franco Cavalli Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 breast cancer.ca
描述The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli- nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has be
出版日期Conference proceedings 1989
關(guān)鍵詞breast cancer; cancer; clinical trial; oncology; quality of life; Radiaton Oncology
版次1
doihttps://doi.org/10.1007/978-3-642-74504-1
isbn_softcover978-3-642-74506-5
isbn_ebook978-3-642-74504-1
copyrightSpringer-Verlag Berlin Heidelberg 1989
The information of publication is updating

書目名稱Endocrine Therapy of Breast Cancer III影響因子(影響力)




書目名稱Endocrine Therapy of Breast Cancer III影響因子(影響力)學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer III網(wǎng)絡(luò)公開(kāi)度




書目名稱Endocrine Therapy of Breast Cancer III網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer III被引頻次




書目名稱Endocrine Therapy of Breast Cancer III被引頻次學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer III年度引用




書目名稱Endocrine Therapy of Breast Cancer III年度引用學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer III讀者反饋




書目名稱Endocrine Therapy of Breast Cancer III讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:25:32 | 只看該作者
Progression from Steroid Responsive to Unresponsive State in Breast Cancer,ifferences or even the derivation of these two classes of breast cancer. The pioneering work of Foulds [1] produced the concept of progression from responsive to unresponsive state in which he stressed that multiple pathways of progression occurred. Unresponsive tumours could be formed from responsi
板凳
發(fā)表于 2025-3-22 01:17:24 | 只看該作者
地板
發(fā)表于 2025-3-22 06:51:23 | 只看該作者
Adjuvant Systemic Therapy for Breast Cancer Patients Without Lymph Node Metastases (N-),cancer and axillary clearance. Patients with N- disease who were treated in the more recent controlled clinical trials have higher relapse rates than those entered in the earlier series from which our perception of prognosis for these patients has been derived. This could be due to a reporting bias,
5#
發(fā)表于 2025-3-22 10:41:46 | 只看該作者
New Developments in the Field of Aromatase Inhibitors, oestrogens may induce regression of tumour growth. In premenopausal women the ovaries are the main source of oestrogens, while in postmenopausal women oestrogens are mainly derived from extra-ovarian aromatisation of androgenic precursors such as androstenedione [1].
6#
發(fā)表于 2025-3-22 14:31:17 | 只看該作者
Resistance to Antioestrogen Therapy: a Challenge for the Future,hough another 20% have stable disease. If oestrogen receptor-positive patients are selected for study, tamoxifen produces a 50–60% objective response rate. Nevertheless, about 13% of oestrogen receptor-negative patients can have a response to therapy.
7#
發(fā)表于 2025-3-22 20:39:18 | 只看該作者
8#
發(fā)表于 2025-3-23 01:01:07 | 只看該作者
9#
發(fā)表于 2025-3-23 02:25:54 | 只看該作者
10#
發(fā)表于 2025-3-23 08:23:12 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 04:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
舟曲县| 平阳县| 郯城县| 收藏| 清河县| 罗源县| 宁远县| 台中市| 临澧县| 永仁县| 淳安县| 神农架林区| 上饶县| 平阴县| 尚志市| 屏东县| 自贡市| 晴隆县| 陆丰市| 宁安市| 德保县| 铁岭县| 通渭县| 兴山县| 外汇| 孟津县| 策勒县| 逊克县| 云安县| 安龙县| 宁陕县| 安溪县| 邵东县| 潼关县| 永嘉县| 绥中县| 杭锦后旗| 天长市| 永安市| 孙吴县| 鹿泉市|